Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 01 04:00PM ET
28.20
Dollar change
+0.34
Percentage change
1.22
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y-4.16% Shs Outstand Perf Week1.72%
SponsorHorizon Kinetics ETF Type Tagsequity Return% 3Y- Total Holdings37 Perf Month-2.99%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM16.57M Perf Quarter-0.88%
Index- Average Maturity Tagspharmaceutical Return% 10Y NAV% Perf Half Y5.33%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-5.25%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range25.88 - 30.81 Perf YTD0.97%
Dividend TTM0.40 (1.43%) ESG Type Tags- Flows% 3M0.00% 52W High-8.46% Beta0.78
Dividend Ex-DateDec 27, 2023 Dividend Type Sector/Theme Flows% YTD0.00% 52W Low8.95% ATR (14)0.25
Expense0.85% Structure Type Region Flows% 1Y RSI (14)49.26 Volatility0.24% 0.42%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.52 Prev Close27.86
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.78K Price28.20
SMA200.62% SMA50-2.98% SMA200-1.00% Trades Volume407 Change1.22%
Horizon Kinetics Medical ETF seeks to provide long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.